Výsledky vyhledávání - "Seminars in oncology"
-
1
KRAS mutation in pancreatic cancer
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.02.2021Vydáno v Seminars in oncology (01.02.2021)“…Pancreatic cancer is a recalcitrant cancer with one of the lowest 5-year survival rates. A hallmark of pancreatic cancer is the prevalence of oncogenic…”
Zjistit podrobnosti o přístupu
Journal Article -
2
Ovarian Cancer: An Integrated Review
ISSN: 0749-2081, 1878-3449, 1878-3449Vydáno: United States Elsevier Inc 01.04.2019Vydáno v Seminars in oncology nursing (01.04.2019)“…To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term…”
Získat plný text
Journal Article -
3
Multiple myeloma epidemiology and survival: A unique malignancy
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.12.2016Vydáno v Seminars in oncology (01.12.2016)“…Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of plasma cell dyscrasias, which…”
Zjistit podrobnosti o přístupu
Journal Article -
4
Modern radiotherapy for head and neck cancer
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.06.2019Vydáno v Seminars in oncology (01.06.2019)“…Radiation therapy (RT) plays a key role in curative-intent treatments for head and neck cancers. Its use is indicated as a sole therapy in early stage tumors…”
Zjistit podrobnosti o přístupu
Journal Article -
5
Cancer and the Immune System: The History and Background of Immunotherapy
ISSN: 0749-2081, 1878-3449, 1878-3449Vydáno: United States Elsevier Inc 01.10.2019Vydáno v Seminars in oncology nursing (01.10.2019)“…This article will outline the link between the immune system and cancer, and provide a historical timeline of immunotherapy developmental milestones. Published…”
Získat plný text
Journal Article -
6
Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.06.2017Vydáno v Seminars in oncology (01.06.2017)“…Glucose is a key metabolite used by cancer cells to generate ATP, maintain redox state and create biomass. Glucose can be catabolized to lactate in the…”
Zjistit podrobnosti o přístupu
Journal Article -
7
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
ISSN: 1532-8708Vydáno: United States 01.08.2015Vydáno v Seminars in oncology (01.08.2015)“…A growing body of evidence suggests that a major subset of patients with advanced solid tumors shows evidence for a T-cell-inflamed tumor microenvironment…”
Zjistit podrobnosti o přístupu
Journal Article -
8
Cervical Cancer: An Overview of Pathophysiology and Management
ISSN: 0749-2081, 1878-3449, 1878-3449Vydáno: United States Elsevier Inc 01.04.2019Vydáno v Seminars in oncology nursing (01.04.2019)“…To provide an overview of the etiology, prevention, diagnosis, treatment, and long-term survivorship concerns surrounding cervical cancer. A review of articles…”
Získat plný text
Journal Article -
9
Implications of reactive oxygen species on cancer formation and its treatment
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.06.2021Vydáno v Seminars in oncology (01.06.2021)“…Elevated levels of reactive oxygen species (ROS) are a hallmark of cancer. Although increased ROS concentrations play important roles in cancer formation and…”
Zjistit podrobnosti o přístupu
Journal Article -
10
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.04.2017Vydáno v Seminars in oncology (01.04.2017)“…T-cell checkpoint inhibition has a profound impact on cancer care and the programmed cell death protein 1 (PD-1)-targeted antibodies nivolumab and…”
Zjistit podrobnosti o přístupu
Journal Article -
11
Axillary surgery in breast cancer: An updated historical perspective
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.12.2020Vydáno v Seminars in oncology (01.12.2020)“…This historical surgical retrospection focuses on the temporal de-escalation axillary surgery, focusing on the unceasing efforts of researchers toward new…”
Zjistit podrobnosti o přístupu
Journal Article -
12
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.02.2024Vydáno v Seminars in oncology (01.02.2024)“…Genome integrity is under constant insult from endogenous and exogenous sources. In order to cope, eukaryotic cells have evolved an elaborate network of DNA…”
Zjistit podrobnosti o přístupu
Journal Article -
13
Cancer and the Immune System: Basic Concepts and Targets for Intervention
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.08.2015Vydáno v Seminars in oncology (01.08.2015)“…A number of consensuses regarding cancer immunology have recently emerged from both preclinical immunotherapy models and analysis of cancer patients. First and…”
Zjistit podrobnosti o přístupu
Journal Article -
14
Antagonists of PD-1 and PD-L1 in Cancer Treatment
ISSN: 1532-8708Vydáno: United States 01.08.2015Vydáno v Seminars in oncology (01.08.2015)“…The PD-1 pathway, comprising the immune cell co-receptor Programmed Death 1 (PD-1) and its ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC), mediates local…”
Zjistit podrobnosti o přístupu
Journal Article -
15
Epidemiology and Overview of Gliomas
ISSN: 0749-2081, 1878-3449, 1878-3449Vydáno: United States Elsevier Inc 01.12.2018Vydáno v Seminars in oncology nursing (01.12.2018)“…To present an overview of gliomas, review risk factors, and prognostic and predictive biomarkers. Published manuscripts and textbook chapters. Molecular…”
Získat plný text
Journal Article -
16
Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.02.2019Vydáno v Seminars in oncology (01.02.2019)“…Lenvatinib is a multikinase inhibitor of vascular endothelial growth factor (VEGF) receptors 1-3, fibroblast growth factor receptors 1-4, RET, KIT, and…”
Zjistit podrobnosti o přístupu
Journal Article -
17
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.02.2024Vydáno v Seminars in oncology (01.02.2024)“…PARP inhibitors have emerged as a promising class of anticancer agents approved for the treatment of ovarian, breast, prostate, and pancreatic cancer. These…”
Zjistit podrobnosti o přístupu
Journal Article -
18
Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.04.2019Vydáno v Seminars in oncology (01.04.2019)“…Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive ductal carcinoma (IDC). Invasive lobular carcinoma has…”
Zjistit podrobnosti o přístupu
Journal Article -
19
Cancer stem cells: the promise and the potential
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.04.2015Vydáno v Seminars in oncology (01.04.2015)“…Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving…”
Zjistit podrobnosti o přístupu
Journal Article -
20
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review
ISSN: 1532-8708, 1532-8708Vydáno: United States 01.06.2021Vydáno v Seminars in oncology (01.06.2021)“…Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication after chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves…”
Zjistit podrobnosti o přístupu
Journal Article